author-photo

Aamnah Ali

Penn State Milton S. Hershey Medical Center

6

Papers

27

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Abstract PD3-10: Higher serum PD-L1 predicts for increased overall survival to lapatinib vs trastuzumab in the phase 3 CCTG MA.31 trial

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer.

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (22)
Elevated serum activin A and PD-L1 and survival in the CCTG MA.31 phase III trial (trastuzumab vs. lapatinib) in first-line HER2+ metastatic breast cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)